Tag:
Immunotherapy
Campaigns
A Dose of Reality: Making Immunotherapy Accessible for Patients with TNBC
Triple-negative breast cancer (TNBC) accounts for approximately 15–20% of all breast cancers and remains one of the most aggressive breast cancer subtypes.¹ Unlike hormone...
Campaigns
Overtreatment in Oncology: Are We Harming Patients with Aggressive Therapy?
Cancer remains a major global health challenge, accounting for nearly one in six deaths worldwide. Simultaneously, oncology has entered an era of unprecedented therapeutic...
News
Targeted Induction of B-cells Using Next-Generation DNA Vaccines: A Breakthrough in HIV Vaccine Development
Targeted Induction of B-cells Using Next-Generation DNA Vaccines: A Breakthrough in HIV Vaccine Development
A primary challenge in contemporary vaccinology and immunotherapy is the induction...
Interview
Effective Method for Generating Immune Cells
The immune system consists of various types of specialized cells. They have specific functions: some destroy cancer cells, some recognize antigens, and others suppress...
Interview
Mastering Locally Advanced Melanoma – Resectable vs Unresectable, Rechallenge Strategies, and Emerging Adjuvant Frontiers
Oncology's precision era hinges on mastering subtle disease staging distinctions that determine life-altering treatment paths, from neoadjuvant immunotherapy combinations that deliver major pathological responses...
Research
The Role of Nutrition in Immunotherapy
Modern medicine increasingly seeks to enhance treatment efficacy by optimizing lifestyle and nutrition. A recent discovery from the Van Andel Institute is a breakthrough...
Interview
Overcoming Barriers to Cell Therapy – From Spatial Immunology to the Scalability Gap
Oncology is at a pivotal moment. The traditional one-size-fits-all approach is giving way to precision medicine - a convergence of genomics, immunology, and advanced...
